A clinical trial of a gene therapy for Angelman syndrome is on hold, Spectrum reports. It adds that two participants experienced an adverse effect that affected their ability to walk.
A clinical trial of a gene therapy for Angelman syndrome is on hold, Spectrum reports. It adds that two participants experienced an adverse effect that affected their ability to walk.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.